More importantly, the suppressed expression of TRIM6 by shRNAs largely attenuated renal fibrosis in vitro and in vivo, suggesting that TRIM6 can be used as a potential therapeutic target for renal fibrosis. This evidence concerns the gene TRIM6 and renal fibrosis.